P. Guilbert, H. Perrin-escalon, and P. Lamoureux, Baromètre santé: nutrition, 2002.

F. Denis, Institut national de prévention et d'éducation pour la santé, 2004.

J. Aiache, Traité de biopharmacie et pharmacocinétique. 2e édition

. Montréal, Vigot Les Presses de l'Université de Montréal, 1990.

P. Allain, Les médicaments. 2e éd. Bouchemaine(49080): CdM Éd, 1999.

X. Fonrose, Cours L2 Pharmacie-Université Joseph Fourier-Grenoble 1-UE Pharmacologie-Pharmacocinétique, 2011.

E. Nicolle, Cours L3 Pharmacie-Université Joseph Fourier-Grenoble 1-UE Pathologies, sciences biologiques et thérapeutiques-« Module » Bases de la conception des substances actives d'origine naturelle et synthétique, 2011.

E. Marieb, K. Hoehn, L. Moussakova, and R. Lachaîne, Anatomie et physiologie humaines. 4ème édition, adaptation de la 8e édition américaine, 2010.

A. Desmedt, Aliments et médicaments: principales interactions, 2011.

A. Astier, Food interactions and oral anticancer therapy, pp.19-27, 2012.

C. Bergström, S. Andersson, J. Fagerberg, G. Ragnarsson, and A. Lindahl, Is the full potential of the biopharmaceutics classification system reached?, European Journal of Pharmaceutical Sciences, vol.57
DOI : 10.1016/j.ejps.2013.09.010

G. Amidon, H. Lennernäs, V. Shah, and J. Crison, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharmaceutical Research, vol.12, issue.3, pp.413-433, 1995.
DOI : 10.1023/A:1016212804288

V. Michaud and J. Turgeon, Les cytochromes P450 et leur rôle clinique-Le médecin du Québec, pp.73-84, 2002.

J. Custodio, C. Wu, L. Benet, S. Kopp, and J. Dressman, Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system Interactions médicamenteuses, cytochromes P450 et P-glycoprotéine (P-gp)-Centre d'informations thérapeutique et de pharmacovigilance Service de pharmacologie et toxicologie cliniques, 717? 33. 15. Lindenberg M, pp.265-78, 2004.

M. Département-de-bio-chimie, Disponible sur: http://esilrch1.esi.umontreal.ca/~syguschj

C. Ribuot, Cours PACES-Université Joseph Fourier-Grenoble 1-UE6

C. Ribuot, Cours PACES-Université Joseph Fourier-Grenoble 1-UE6

C. Ribuot, Cours PACES-Université Joseph Fourier-Grenoble 1-UE6

B. Jáuregui-garrido, Jáuregui-Lobera I. Interactions between antihypertensive drugs and food, Nutr Hosp. déc, vol.27, issue.6, pp.1866-75, 2012.

B. Durand, Pourquoi et comment évaluer les interactions médicaments-aliments chez le sujet âgé ? [Thèse d'exercice], 2015.

M. Morgand, A. Lopes, C. Lloret-linares, and J. Bergmann, Interactions médicaments?aliments en médecine interne : quels messages pour le clinicien ? Rev, Pharma-Flash, vol.29, issue.5, 2002.

D. Genser, Food and Drug Interaction: Consequences for the Nutrition/Health Status, Annals of Nutrition and Metabolism, vol.52, issue.1, pp.29-32, 2008.
DOI : 10.1159/000115345

L. Chan, J. Boullata, and L. Hudson, Drug-nutrient interaction in clinical nutrition Drug?Nutrient Interactions: A Broad View with Implications for Practice, Curr Opin Clin Nutr Metab Care. mai J Acad Nutr Diet. avr, vol.5112, issue.34, pp.327-359, 2002.

B. Bonaz, Cours PACES-Université Joseph Fourier-Grenoble 1-UE5 Organisation des appareils et systèmes : aspects fonctionnels et méthodes d'étude

. Physiologie-digestive-chapitre, Disponible sur: http://unf3s.cerimes.fr/media/paces/Grenoble_1112/bonaz_bruno/bonaz_bruno_p02/index .htm 31. Saivin S, Houin G. Nutrition et médicaments: mise au point sur les aspects pharmacocinétiques, Rev Fr Lab. juin, vol.2, issue.334, pp.65-70, 2001.

S. Faure, Interactions des médicaments avec l'alimentation

N. Trevaskis, W. Charman, and C. Porter, Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update Rainsford KD, Bjarnason I. NSAIDs: take with food or after fasting?: NSAIDs and food, Adv Drug Deliv Rev. mars J Pharm Pharmacol. avr, vol.6064, issue.344, pp.702-16465, 2008.

R. Moore, S. Derry, P. Wiffen, and S. Straube, Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs - a systematic review, British Journal of Clinical Pharmacology, vol.160, issue.12 Suppl, pp.381-389, 2015.
DOI : 10.1001/archinte.160.14.2093

I. Extrudate, Rapidly Dissolving Ibuprofen Formulation: Relative Bioavailability Compared to Ibuprofen Lysinate and Regular Ibuprofen, and Food Effect on All Formulations, J Clin Pharmacol. sept, vol.45, issue.9, pp.1055-61, 2005.

R. Moore, S. Derry, P. Wiffen, and S. Straube, Reply to ???Effects of food on pharmacokinetics of immediate release oral formulations???, British Journal of Clinical Pharmacology, vol.12, issue.5, pp.1238-12381243, 2015.
DOI : 10.1002/14651858.CD009281.pub3

K. Heintze, W. Fuchs, and K. Baxter, Effects of food on pharmacokinetics of immediate release oral formulations Stockley's drug interactions: a source book of interactions, their mechanisms, clinical importance and management Oxford: Blackwell Scientific; 1981. 41, 1239? 1239. 40. Stockley IH, 2010.

A. Four-way, Crossover Study to Compare the Concentration?Time Profile of Paracetamol from the New Paracetamol/Sodium Bicarbonate Tablet and a Conventional Paracetamol Tablet in Fed and Fasted Volunteers, 523? 31. 42. Bartholomé R, 2002.

A. Zahri, K. L-'hauchecorne, R. Vinckier, C. Hoogmartens, and J. , Université de Nancy I. UFR Sciences pharmaceutiques et biologiques, 2009.

Y. Kim, T. Heinze, R. Beger, J. Pothuluri, C. Cerniglia et al., A kinetic study on the degradation of erythromycin A in aqueous solution Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy, Fiche CHLORAMINOPHENE® professionnels de santé-Version de janvier, pp.63-76, 2004.

M. Omédit-de-haute-normandie-borin, M. Driver, K. Forbes, M. Borin, K. Forbes et al., Effect of timing of food on absorption of cefpodoxime proxetil Effect of food on absorption of cefpodoxime proxetil oral suspension in adults Effect of timing of food on absorption of cefpodoxime proxetil Effect of food on absorption of cefpodoxime proxetil oral suspension in adults The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil, Disponible sur Sommers DK, van Wyk M, Moncrieff J, Schoeman HS. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil, pp.273-278, 1989.

D. Carson, Cefuroxime Axetil (Ceftin®): A Brief Review, Clin Pharmacol. oct Infect Dis, vol.18, issue.4, 1984.

A. Straughn, M. Meyer, J. Chubb, K. Danielson, B. Scherstén et al., Effect of dose and food on the bioavailability of cefuroxime axetil Overdiek HW, Merkus FW. Influence of food on the bioavailability of spironolactone Enhancement by food of canrenone bioavailability from spironolactone, Obstet Gynecol. Biopharm Drug Dispos. déc Clin Pharmacol Ther. nov Clin Pharmacol Ther. juill, vol.584022, issue.3651, pp.519-545, 1977.

M. Tod and . Sources-de-variabilité-de-la-pharmacocinétique, Disponible sur: spiralconnect.univ-lyon1.fr/spiral- files/download?mode=inline&data=6752630 60, Loichot C, Grima M. Cours DCEM1-Faculté de Médecine de Strasbourg-Module de Pharmacologie Générale-Chapitre 3-Résorption-Absorption. [Internet], 2004.

J. Saulnier and M. Talbert, Médicaments, heure, tabac et alimentation

L. Garrec and D. , Mise au point de micelles polymères pour la formulation d'agents anticancéreux hydrophobes [Internet] Disponible sur: https://papyrus.bib.umontreal.ca/xmlui/handle/1866/15655 63. Ogunbona FA, Smith IF, Olawoye OS. Fat contents of meals and bioavailability of griseofulvin in man, J Pharm Pharmacol. avr, vol.37, issue.4, pp.283-287, 1985.

N. Aoyagi, H. Ogata, N. Kaniwa, and A. Ejima, Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEGR) plain tablets., Journal of Pharmacobio-Dynamics, vol.5, issue.2, pp.120-124, 1982.
DOI : 10.1248/bpb1978.5.120

. Haute-normandie, Disponible sur: http://www.omedithautenormandie .fr/Files/tyverb_fiche_medecin_pharma_janv2016.pdf 67 Monographie du médicament consulté via la banque de données Thériaque entre 06, 2016.

A. Haute-normandie-abuhelwa, D. Foster, and R. Upton, A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption???Part I: Gastrointestinal pH, The AAPS Journal, vol.18, issue.5, pp.1309-1330, 2016.
DOI : 10.1208/s12248-016-9952-8

H. Bahri, A. Douaoui, and M. Gharbi, Point sur les interactions médicamentaliments, Batna J Med Sci, vol.1, pp.100-106, 2014.

C. Chang, Y. Wang, Y. Liu, P. , K. Yang et al., A practical approach to minimize the interaction of dietary vitamin K with warfarin Disponible sur: https://pro.anses.fr/tableciqual/index.htm 73. ANSES. Table de composition nutritionnelle des aliments Ciqual Vitamin K: a practical guide to the dietary management of patients on warfarin Paris: Maloine, 56? 60. 72. ANSES. Table de composition nutritionnelle des aliments Ciqual 2016 -Vitamine K1 [Internet]. 2016, 1979.

F. Pedersen, O. Hamberg, K. Hess, L. Ovesen, B. Leijd et al., 10):e2895. 78. Booth SL. Dietary vitamin K guidance: an effective strategy for stable control of oral anticoagulation? HAS. Synthèse des recommandations professionnelles-Prise en charge des surdosages en antivitamines K, des situations à risque hémorragique et des accidents hémorragiques chez les patients traités par antivitamines K en ville et en milieu hospitalier Disponible sur: https://www.hassante.fr/portail/upload/docs/application/pdf/2008- 09/surdosage_en_avk_situations_a_risque_et_accidents_hemorragiques_- _synthese_des_recommandations_v2.pdf 80 The effect of dietary vitamin K on warfarin-induced anticoagulation On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment Vitamin K intake and sensitivity to warfarin in patients consuming regular diets, Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review, pp.178-81, 1986.

T. Khan, H. Wynne, P. Wood, A. Torrance, C. Hankey et al., Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin, British Journal of Haematology, vol.5, issue.3
DOI : 10.1079/BJNBJN2002583

L. Rohde, M. De-assis, and E. Rabelo, Dietary vitamin K intake and anticoagulation in elderly patients, Current Opinion in Internal Medicine, vol.6, issue.2, pp.1-5, 2007.
DOI : 10.1097/MCO.0b013e328011c46c

E. Bovill, M. Fung, and M. Cushman, Vitamin K and oral anticoagulation: thought for food, 711? 3. 87. ANSM. Bon usage des médicaments antivitamine K (AVK) -Actualisation? Juillet, 2004.
DOI : 10.1016/j.amjmed.2004.02.020

I. Ansm, Disponible sur: http://ansm.sante.fr/var/ansm_site/storage/original/application/6d550a9311848623e57d31 1cc0ebacbe.pdf 88. ANSES. Table de composition nutritionnelle des aliments Ciqual 2016 -Calcium [Internet]. 2016. Disponible sur: https://pro.anses.fr/tableciqual/index, 2012.

M. Apfelbaum, M. Romon, and M. Dubus, Diététique et nutrition

H. Jung, A. Peregrina, J. Rodriguez, R. Moreno-esparza, C. Mundo et al., The influence of coffee with milk and tea with milk on the bioavailability of tetracycline Influence of the diet on bioavailability of tetracycline, 549? 53. 93. Association Mieux Prescrire, éditeur. 1.18 -Fixation de substances et formation de complexes en bref. In: Petit manuel de Pharmacovigilance et Pharmacologie clinique, 1993.

F. Meyer, Minocycline for acne. Food reduces minocycline's bioavailability
DOI : 10.1136/bmj.312.7038.1101

P. Welling, P. Koch, C. Lau, W. Craig, K. Kivistö et al., Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects Interference of dairy products with the absorption of ciprofloxacin Ciprofloxacin pharmacokinetics after a standard or high-fat/high-calcium breakfast, 462? 9. 96. Neuvonen PJ, pp.953-958, 1977.

R. Minami, N. Inotsume, M. Nakano, Y. Sudo, A. Higashi et al., Effect of milk on absorption of norfloxacin in healthy volunteers Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension, J Clin Pharmacol. déc J Antimicrob Chemother. mars, vol.3343, issue.12, pp.49-54, 1993.

L. Lee, B. Hafkin, I. Lee, J. Hoh, and R. Dix, Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects, Antimicrob Agents Chemother. oct, vol.41, issue.10, pp.2196-200, 1997.

P. Neuvonen and K. Kivistö, Milk and yoghurt do not impair the absorption of ofloxacin., British Journal of Clinical Pharmacology, vol.35, issue.Suppl. 1, pp.346-354, 1992.
DOI : 10.1128/AAC.35.2.384

M. Dudley, C. Marchbanks, S. Flor, and B. Beals, The effect of food or milk on the absorption kinetics of ofloxacin, European Journal of Clinical Pharmacology, vol.10, issue.1, pp.569-71, 1991.
DOI : 10.1007/BF00314986

H. Stass and D. Kubitza, Profile of Moxifloxacin Drug Interactions, Clinical Infectious Diseases, vol.32, issue.Supplement_1, pp.47-50, 2001.
DOI : 10.1086/319376

M. Francis and D. Valent, Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases, J Musculoskelet Neuronal Interact. mars, vol.7, issue.1, pp.2-8, 2007.

S. Cremers and S. Papapoulos, Pharmacology of bisphosphonates, Bone, vol.49, issue.1, pp.42-51, 2011.
DOI : 10.1016/j.bone.2011.01.014

A. Ezra and G. Golomb, Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption, Advanced Drug Delivery Reviews, vol.42, issue.3, pp.175-95, 2000.
DOI : 10.1016/S0169-409X(00)00061-2

D. Mitchell, M. Heise, K. Pallone, M. Clay, J. Nesbitt et al., The effect of dosing regimen on the pharmacokinetics of risedronate, British Journal of Clinical Pharmacology, vol.15, issue.4, pp.536-578, 1999.
DOI : 10.1038/clpt.1982.51

A. Melander, P. Stenberg, H. Liedholm, B. Scherstén, and E. Wåhlin-boll, Food-induced reduction in bioavailability of atenolol, European Journal of Clinical Pharmacology, vol.27, issue.Suppl. 2, pp.327-357, 1979.
DOI : 10.1007/BF00605630

P. Kahela, M. Anttila, R. Tikkanen, and H. Sundquist, Effect of Food, Food Constituents and Fluid Volume on the Bioavailability of Sotalol, Acta Pharmacologica et Toxicologica, vol.5, issue.Supplement 2, pp.7-12, 1979.
DOI : 10.1002/cpt1974163part1465

S. Barnwell, T. Laudanski, M. Dwyer, M. Story, P. Guard et al., Reduced bioavailability of atenolol in man: the role of bile acids, International Journal of Pharmaceutics, vol.89, issue.3, pp.245-50, 1993.
DOI : 10.1016/0378-5173(93)90250-J

K. Baum, Atlas de poche de nutrition. 2e édition. Paris: Lavoisier-Médecine sciences, 2017.

C. Coatrieux, Monoamine oxydases et athérosclérose: signalisation mitogène et étude in vivo, 2007.

C. Brown, G. Taniguchi, and K. Yip, The Monoamine Oxidase Inhibitor-Tyramine Interaction, The Journal of Clinical Pharmacology, vol.3, issue.6, pp.529-561, 1989.
DOI : 10.1097/00004714-198308000-00011

U. Bonnet, Moclobemide: Therapeutic Use and Clinical Studies, CNS Drug Reviews, vol.82, issue.Suppl 360, pp.97-140, 2003.
DOI : 10.1093/schbul/6.2.324

J. Adam, Traitements anticancéreux oraux des tumeurs solides (1re partie), 2012.

N. Fernandez, J. Garcia, M. Diez, A. Sahagun, R. Díez et al., Effects of dietary factors on levodopa pharmacokinetics, Expert Opinion on Drug Metabolism & Toxicology, vol.99, issue.1, pp.633-675, 2010.
DOI : 10.1586/ern.09.48

E. Cereda, M. Barichella, and G. Pezzoli, Controlled-protein dietary regimens for Parkinson's disease, Nutritional Neuroscience, vol.253, issue.7, pp.29-32, 2010.
DOI : 10.1097/00002826-199210000-00004

E. Cereda, M. Barichella, C. Pedrolli, and G. Pezzoli, Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review, Movement Disorders, vol.129, issue.Suppl 1, pp.2021-2055, 2010.
DOI : 10.1001/archneur.1992.00530260049018

A. Bonnici, C. Ruiner, L. St-laurent, and D. Hornstein, An Interaction Between Levodopa and Enteral Nutrition Resulting in Neuroleptic Malignant-Like Syndrome and Prolonged ICU Stay, Annals of Pharmacotherapy, vol.110, issue.1, pp.1504-1511, 2010.
DOI : 10.1007/s00702-003-0081-z

C. Whitman, E. Ablordeppey, and B. Taylor, Levodopa Withdrawal Presenting as Fever in a Critically Ill Patient Receiving Concomitant Enteral Nutrition, Journal of Pharmacy Practice, vol.30, issue.1, pp.574-582, 2016.
DOI : 10.2146/ajhp080434

N. Simon, R. Gantcheva, B. Bruguerolle, and F. Viallet, The effects of a normal protein diet on LevoDOPA plasma kinetics in advanced Parkinson's disease, Parkinsonism & Related Disorders, vol.10, issue.3, pp.137-179, 2004.
DOI : 10.1016/j.parkreldis.2003.10.004

L. and |. Anses-, Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail-Mis à jour le 01, ANSES-Agence nationale de sécurité sanitaire de l'alimentation, 2016.

Y. Liel, I. Harman-boehm, and S. Shany, Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients, J Clin Endocrinol Metab. févr, vol.81, issue.2, pp.857-866, 1996.

L. Liwanpo and J. Hershman, Conditions and drugs interfering with thyroxine absorption, Best Practice & Research Clinical Endocrinology & Metabolism, vol.23, issue.6, pp.781-92, 2009.
DOI : 10.1016/j.beem.2009.06.006

M. Fernandez-martinez, L. Hernandez-echevarria, M. Sierra-vega, M. Diez-liebana, A. Calle-pardo et al., A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters, BMC Complementary and Alternative Medicine, vol.37, issue.1, p.296, 2014.
DOI : 10.1124/dmd.108.026229

. Jury-de-la-conférence, La Maladie de Parkinson : critères diagnostiques et thérapeutiques-Texte des Recommandations In Amphithéâtre Charcot ? Hôpital de la Pitié Salpétrière -Paris; 2000. p. 29 pages. Disponible sur: https

S. Ladha, R. Walker, and H. Shill, Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance, Movement Disorders, vol.9, issue.5, pp.630-631, 2005.
DOI : 10.1212/WNL.52.4.777

H. Baribeau, Régime équilibre acido-basique [Internet]. Passeportsante.net, 2014.

A. Lombart, Alimentation-Généralités-Tableau des aliments [Internet] Association Française de la Cystite Interstitielle, pp.3-9

M. Fiche and . Bellon®-professionnels-de-santé, Version de janvier 2016-OMéDIT de Haute-Normandie

F. Maton, Les eaux minérales et leurs teneurs

C. Bernaud, Consommation de thé et de médicaments: que doit savoir le pharmacien à l'officine ? [Thèse d'exercice, 2014.

J. Bruneton and E. Poupon, Pharmacognosie, phytochimie, plantes médicinales. 5e édition, 2016.

F. Maillet, Les vertus médicinales du thé (Camellia sinensis, Ternstroemiaceae): du mythe à la réalité [Thèse d'exercice, Nantes, 2003.

G. Gabrielli, D. Sandre, and G. , Excessive tea consumption can inhibit the efficacy of oral iron treatment in iron-deficiency anemia, Haematologica. déc, vol.80, issue.6, pp.518-538, 1995.

U. Mahlknecht, E. Weidmann, and G. Seipelt, The irreplaceable image: Black tea delays recovery from iron-deficiency anemia, Haematologica. mai, vol.86, issue.5, p.559, 2001.

M. Perry, Herboristerie : enquête sur les principales demandes à l'officine, 2013.

S. Navarette and C. Saussays, Les interactions entre plantes et médicaments, 2011.

P. Delaveau and É. Wolff, Académie nationale de pharmacie. Dictionnaire des sciences pharmaceutiques & biologiques Pariente, Paris: Éd. L, 1997.

G. Mazzanti, D. Sotto, A. Vitalone, and A. , Hepatotoxicity of green tea: an update, Archives of Toxicology, vol.36, issue.501???6, pp.1175-91, 2015.
DOI : 10.1081/DMR-120028427

G. Mazzanti, F. Menniti-ippolito, P. Moro, F. Cassetti, R. Raschetti et al., Hepatotoxicity from green tea: a review of the literature and two unpublished cases, European Journal of Clinical Pharmacology, vol.20, issue.4
DOI : 10.1177/147323000303100205

URL : https://hal.archives-ouvertes.fr/hal-00534939

. Avis, Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail relatif au risque d'hépatotoxicité lié à la consommation de denrées alimentaires contenant notamment du thé vert

. Nan-108, Disponible sur: https://www.anses.fr/fr/system/files

. Avis, Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail relatif à la sécurité d'emploi des préparations de thé vert, NUT2011sa0139.pdf 155. International Coffee Organisation-CoffeeTradeStats Country Infographics

. France, Disponible sur: https://infogram, p.0, 2017.

P. Haler, Le café : les effets bénéfiques et néfastes sur la santé, 2013.

A. Bonnin, Autour du café [Thèse d'exercice]. [France]: Université d'Angers, 2016.

P. Nathan and . Le, Disponible sur: https, en chiffres. janv, vol.5, issue.29, 2007.

K. Nieber, Abstract, Planta Medica, vol.4, 2017.
DOI : 10.1055/s-0043-115007

A. Huyghe, Bienfaits et limites de la consommation de caféine

S. Mouly, Disponible sur: regis.sainz.free.fr/cours_M2/UE1, Etats%20pathologiques%20-%20Mouly.ppt 163. Interactions médicamenteuses et cytochromes -ANSM : Agence nationale de sécurité du médicament et des produits de santé [Internet]. [cité 6 sept 2017]. Disponible sur, 2017.

J. Carrillo and J. Benitez, Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications, Clinical Pharmacokinetics, vol.23, issue.8, pp.127-53, 2000.
DOI : 10.1249/00005768-199108000-00016

D. Healy, R. Polk, L. Kanawati, D. Rock, and M. Mooney, Interaction between oral ciprofloxacin and caffeine in normal volunteers., Antimicrobial Agents and Chemotherapy, vol.33, issue.4, pp.474-482, 1989.
DOI : 10.1128/AAC.33.4.474

C. Camponovo, Distribution de la fraction d'excrétion rénale du lithium et de l'acide urique dans l'étude de population Hercules, 2011.

. Wolf, Faculté de Médecine de Strasbourg-DCEM3-Pharmacologie Chap 6-Les Thymorégulateurs

N. Benowitz, Clinical Pharmacology of Caffeine, Annual Review of Medicine, vol.41, issue.1, pp.277-88, 1990.
DOI : 10.1146/annurev.me.41.020190.001425

K. Nieber, Abstract, Planta Medica, 2017.
DOI : 10.1055/s-0043-115007

E. Boué-grabot and N. Rebola, Les purines : des acteurs clés de la neuromodulation du système nerveux central, Lett Neurosci. nov, issue.47, pp.12-16, 2014.

]. Internet and . Vidal, Disponible sur: https://evidal-vidalfr .gaelnomade-2.grenet.fr/recos/details/1619/insomnie_de_l_adulte/prise_en_charge 173. Trouble anxieux généralisé-Prise en charge-VIDAL-eVidal-Mise à jour du 24, 2017.

R. Hurrell, M. Reddy, and J. Cook, Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages, Br J Nutr. avr, vol.81, issue.4, pp.289-95, 1999.

. Avis, Anses -Rapport d'expertise collective, pp.24-535

F. Courtet-leymarios, Qualité nutritionnelle du lait de vache et de ses acides gras: voies d'amélioration par l'alimentation [Thèse d'exercice], 2010.

N. Burton, M. Barnett, G. Aherne, J. Evans, I. Douglas et al., The effect of food on the oral administration of 6-mercaptopurine, Cancer Chemotherapy and Pharmacology, vol.308, issue.1, pp.90-91, 1986.
DOI : 10.1007/BF00253074

P. Fiche, M. De-santé-de-lemos, L. Hamata, S. Jennings, and T. Leduc, Version de janvier 2016-OMéDIT de Haute-Normandie [Internet] Disponible sur: http://www.omedithautenormandie .fr/Files/purinethol_fiche_medecin_pharma_janv2016.pdf 184 Interaction between mercaptopurine and milk (abstract), J Oncol Pharm Pract. déc, vol.13, issue.4, pp.237-277, 2007.

C. Andrade, Fruit Juice, Organic Anion Transporting Polypeptides, and Drug Interactions in Psychiatry, The Journal of Clinical Psychiatry, vol.75, issue.11, pp.1323-1325, 2014.
DOI : 10.4088/JCP.14f09572

G. Dresser and D. Bailey, The effects of fruit juices on drug disposition: a new model for drug interactions, European Journal of Clinical Investigation, vol.109, issue.s2, pp.10-16, 2003.
DOI : 10.1067/mcp.2001.118867

M. Multeau, Quelles boissons prendre avec ses médicaments?

D. Bailey, Fruit juice inhibition of uptake transport: a new type of food-drug interaction, British Journal of Clinical Pharmacology, vol.43, issue.182, pp.645-55, 2010.
DOI : 10.1177/0091270003253399

B. Kirby and J. Unadkat, Grapefruit Juice, a Glass Full of Drug Interactions?, Clinical Pharmacology & Therapeutics, vol.70, issue.5, pp.631-634, 2007.
DOI : 10.1038/sj.clpt.6100185

D. Bailey, Predicting clinical relevance of grapefruit-drug interactions: a complicated process, Journal of Clinical Pharmacy and Therapeutics, vol.310, issue.2, pp.125-132, 2017.
DOI : 10.1001/jama.2013.282426

M. Dolton, B. Roufogalis, and A. Mclachlan, Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion???Transporting Polypeptides, Clinical Pharmacology & Therapeutics, vol.57, issue.5, pp.622-652, 2012.
DOI : 10.1046/j.1365-2125.2003.02030.x

D. Genser, Food and Drug Interaction: Consequences for the Nutrition/Health Status, Annals of Nutrition and Metabolism, vol.52, issue.1, pp.29-32, 2008.
DOI : 10.1159/000115345

M. Youdim, D. Edmondson, and K. Tipton, The therapeutic potential of monoamine oxidase inhibitors, Nature Reviews Neuroscience, vol.47, issue.4, pp.295-309, 2006.
DOI : 10.1212/01.WNL.0000148603.44618.19

B. Jáuregui-garrido, Jáuregui-Lobera I. Interactions between antihypertensive drugs and food, Nutr Hosp. déc, vol.27, issue.6, pp.1866-75, 2012.

R. Bard, B. Bleske, and J. Nicklas, Food: An Unrecognized Source of Loop Diuretic Resistance, Pharmacotherapy, vol.8, issue.2, pp.630-637, 2004.
DOI : 10.2165/00003495-198530050-00003

J. Mccrindle, L. K. Wa, T. Barron, W. Prescott, and L. , Effect of food on the absorption of frusemide and bumetanide in man, British Journal of Clinical Pharmacology, vol.42, issue.6, pp.743-749, 1996.
DOI : 10.1046/j.1365-2125.1996.00494.x

I. Stockley and K. Baxter, Stockley's drug interactions: a source book of interactions, their mechanisms, clinical importance and management Oxford: Blackwell Scientific, 1981.

A. Salvetti, R. Pedrinelli, A. Magagna, B. Abdel-haq, L. Graziadei et al., Influence of Food on Acute and Chronic Effects of Captopril in Essential Hypertensive Patients, Journal of Cardiovascular Pharmacology, vol.7, issue.Supplement 1, pp.25-29, 1985.
DOI : 10.1097/00005344-198507001-00006

Z. Israili, Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension, Journal of Human Hypertension, vol.14, issue.s1, pp.73-86, 2000.
DOI : 10.1038/sj.jhh.1000991

S. Faure, Interactions des médicaments avec l'alimentation, Disponible sur, p.157, 2008.

H. Bahri, A. Douaoui, and M. Gharbi, Point sur les interactions médicament-aliments, Batna J Med Sci, vol.1, pp.100-106, 2014.

F. Martínez and N. , Dietary fiber and its interaction with drugs, Nutr Hosp. 1 juin, issue.4, pp.535-539, 2010.

J. Stampfuss, D. Kubitza, M. Becka, and W. Mueck, The effect of food on the absorption and pharmacokinetics of rivaroxaban, Int. Journal of Clinical Pharmacology and Therapeutics, vol.51, issue.07, pp.549-61, 2013.
DOI : 10.5414/CP201812

A. Amin, Choosing Non-Vitamin K Antagonist Oral Anticoagulants: Practical Considerations We Need to Know

E. Nutescu, I. Chuatrisorn, and E. Hellenbart, Drug and dietary interactions of warfarin and novel oral anticoagulants: an update Beyer-Westendorf J, Siegert G. Of men and meals, J Thromb Thrombolysis. avr J Thromb Haemost. juin, vol.3113, issue.146, pp.326-43943, 2011.

J. Cheng and G. Barillari, Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions Adiguzel C. Drug and dietary interactions of the new and emerging oral anticoagulants: Drug interactions of new oral anticoagulants, J Clin Pharm Ther. avr Walenga JM Int J Clin Pract. juin, vol.3964, issue.27, pp.118-153, 2010.

R. Moore, S. Derry, P. Wiffen, and S. Straube, Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs - a systematic review, British Journal of Clinical Pharmacology, vol.160, issue.12 Suppl
DOI : 10.1001/archinte.160.14.2093

F. Hurbin, X. Boulenc, N. Daskalakis, C. Farenc, T. Taylor et al., Clopidogrel Pharmacodynamics and Pharmacokinetics in the Fed and Fasted State: A Randomized Crossover Study of Healthy Men Effect of food on the bioavailability and tolerance of clavulanic acid/amoxycillin combination, 131? 9. 22. Curatolo W, Foulds G, LaBadie R. Mechanistic Study of the Azithromycin Dosage-Form-Dependent Food Effect, pp.1506-1521, 1982.

S. Chu, Y. Park, C. Locke, D. Wilson, and J. Cavanaugh, Drug-Food Interaction Potential of Clarithromycin, A New Macrolide Antimicrobial, The Journal of Clinical Pharmacology, vol.2, issue.supp 1, pp.32-38, 1992.
DOI : 10.3109/inf.1978.10.issue-2.07

S. Saivin, G. J. Houin, J. Biollaz, P. Bonnabry, T. Buclin et al., Nutrition et médicaments: mise au point sur les aspects pharmacocinétiques Interactions des médicaments avec l'alimentation. Pharma-Flash, Rev Fr Lab. juin, vol.29, issue.3345, pp.17-21, 2001.
DOI : 10.1016/s0338-9898(01)80199-2

J. Saulnier and M. Talbert, Médicaments, heure, tabac et alimentation, DL, 1988.

K. Erdman, D. Stypinski, M. Combs, P. Witt, M. Stiles et al., Absence of food effect on the extent of alprazolam absorption from an orally disintegrating tablet Different effects of light food on pharmacokinetics and pharmacodynamics of three benzodiazepines, quazepam, nitrazepam and diazepam, Pharmacotherapy. août J Clin Pharm Ther. févr, vol.2732, issue.81, pp.31-40, 2007.

J. Jeppsson, J. Sjögren, B. Flannery, J. Campestrini, S. Leon et al., The influence of food on side effects and absorption of lithium Effect of food on the pharmacokinetics of a vildagliptin/metformin (50/1000 mg) fixed-dose combination tablet in healthy volunteers, Acta Psychiatr Scand. mai Curr Med Res Opin. juin, vol.5124, issue.46, pp.1703-1712, 1975.

P. Marathe, M. Arnold, J. Meeker, D. Greene, and R. Barbhaiya, Pharmacokinetics and bioavailability of a metformin/glyburide tablet administered alone and with food, J Clin Pharmacol. déc, vol.40, pp.1494-502, 2000.

A. Scheen and J. Hershman, Pharmacokinetics of dipeptidylpeptidase-4 inhibitors Conditions and drugs interfering with thyroxine absorption, Diabetes Obes Metab. août Best Pract Res Clin Endocrinol Metab. déc, vol.1223, issue.86, pp.781-92, 2009.

M. Sostek, Y. Chen, and T. Andersson, Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole, British Journal of Clinical Pharmacology, vol.64, issue.3, pp.386-90, 2007.
DOI : 10.1007/s00228-004-0841-1

O. Junghard, M. Hassan-alin, and G. Hasselgren, The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH, European Journal of Clinical Pharmacology, vol.58, issue.7, pp.453-461, 2002.
DOI : 10.1007/s00228-002-0502-1

J. Hatlebakk, P. Katz, L. Camacho-lobato, and D. Castell, Proton pump inhibitors: better acid suppression when taken before a meal than without a meal, Alimentary Pharmacology and Therapeutics, vol.4, issue.10, pp.1267-72, 2000.
DOI : 10.1046/j.1365-2036.1998.00426.x

A. Astier, Food interactions and oral anticancer therapy, pp.19-27, 2012.

F. Saint-marcoux, Pharmacocinétique et suivi thérapeutique pharmacologique de la ciclosporine en transplantation d'organes solides, 2004.

I. Bekersky, D. Dressler, and Q. Mekki, Effect of Low- and High-Fat Meals on Tacrolimus Absorption following 5 mg Single Oral Doses to Healthy Human Subjects, The Journal of Clinical Pharmacology, vol.86, issue.2, pp.176-82, 2001.
DOI : 10.1177/00912709922011791